ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report) shares fell 6.7% on Thursday . The company traded as low as $37.9150 and last traded at $37.9150. Approximately 100 shares were traded during trading, a decline of 81% from the average session volume of 525 shares. The stock had previously closed at $40.65.
ALK-Abelló A/S Price Performance
The company’s fifty day simple moving average is $38.62 and its 200-day simple moving average is $35.91.
About ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
See Also
- Five stocks we like better than ALK-Abelló A/S
- Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop
- Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs?
- The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story
- Why Intuitive Surgical’s Strong Quarter Still Spooked Investors
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
